ArticleArchives of medical sciences. Atherosclerotic diseases2022

Therapeutic versus prophylactic heparin for thromboprophylaxis in patients with COVID-19: weighing the costs and benefits. A rapid meta-analysis of randomized controlled trials.

Athina Dimosiari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.